Medivive was built around a simple idea: NAD+ therapy should be accessible, consistent, and easy to prescribe. Our prefilled NAD+ injector pen is the first of its kind in the United States, delivering 1,000 mg of pharmaceutical-grade, preservative-free NAD+ in a format that patients can self-administer at home.
NAD+ is a central metabolic cofactor involved in over 500 enzymatic reactions, including DNA repair via PARPs and metabolic regulation through sirtuins. Tissue levels decline significantly with age, and restoring them has shown meaningful effects on energy, cognitive clarity, and cellular resilience. Subcutaneous delivery provides near-complete bioavailability and a sustained-release profile, avoiding the rapid spike and drop associated with IV administration.
Our pen is manufactured by VeV Scientific, an FDA-registered 503B outsourcing facility in San Diego operating under cGMP standards in an ISO-certified cleanroom. Dispensing is handled by Chemistry Rx, a PCAB-accredited, LegitScript-certified 503A pharmacy. Every pen ships cold-chain via FedEx directly to the patient, so practices carry zero inventory and take on no logistics burden.
For providers, prescribing takes under two minutes through our online portal. All supplies are included, patient onboarding is handled by our team, and auto-refill keeps patients on protocol without extra work for your staff. The pen creates meaningful recurring revenue while offering patients a more convenient and affordable alternative to IV NAD+ sessions.
We built Medivive for clinicians who take cellular medicine seriously and want a reliable, compliant way to integrate NAD+ into their practice. No vials, no syringes, no guesswork. Just a better way to deliver NAD+.